December 31, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in adults ...

BOSTON, March 28, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial ...

Kyverna reported $286.0M in cash, cash equivalents, and available-for-sale marketable securities as of December 31, 2024. The company expects ...

Meta Platforms' net cash and marketable securities position reached a record high to close out 2024. Read why I remain ...

Q4 2024 Earnings Call Transcript March 27, 2025 BioRestorative Therapies, Inc. beats earnings expectations. Reported EPS is $ ...

Acumen Pharmaceuticals Inc (ABOS) reports robust cash reserves and advances in Alzheimer's research, despite increased R&D expenses and competitive challenges.

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision ...

We recently published a list of 15 Cheapest Stocks Insiders Are Buying In March. In this article, we are going to take a look ...

Discover why high valuations, cash burn concerns, and weak financial reporting make this stock a strong sell despite ...

TORONTO, March 28, 2025 (GLOBE NEWSWIRE) -- Partners Value Investments Inc. (the “Company”, TSX: PVF.WT, PVF.PR.V) announced today its financial results for the year ended December 31, 2024. All ...

Arbutus is also exiting its corporate headquarters in Pennsylvania and will terminate all in-house scientific research. The ...